Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbusinesswire.com
Business Wire Health: FDA News
Get the latest updates from Business Wire Health: FDA News directly as they happen.
Follow now 109 followers
Latest posts
Last updated about 12 hours ago
Aviva Bio’s AVA-291 Emerges as Best-in-Class Therapy to Address FDA-Identified Safety Concerns of Testosterone for Women
about 12 hours ago
CONCORD, Mass.--(BUSINESS WIRE)--Aviva Bio, a biotechnology company developing next-generation hormone therapies, highlighted...
MaaT Pharma annonce la tenue prochaine d’une réunion pré-IND avec la FDA et poursuit l’avancement de MaaT034 vers son développement clinique dans les tumeurs solides
about 13 hours ago
LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT : MAAT - la «...
MaaT Pharma Announces Upcoming Pre-IND Meeting with the FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors
about 13 hours ago
LYON, France--(BUSINESS WIRE)---- $MAAT #Cancer--MaaT Pharma Announces Upcoming Pre-IND Meeting with the...
Dutch Medical Device Maker, Medical Precision, Enters U.S. Market With FDA-Cleared Comfort Marker
about 13 hours ago
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Medical Precision Inc., a Dutch medical device company, today announced...
Le meilleur semestre de l’histoire de Curatis — Chiffre d’affaires en hausse de 51 % et progrès significatifs concernant la corticoréline (C-PTBE-01)
about 15 hours ago
LIESTAL, Suisse--(BUSINESS WIRE)--Curatis Holding AG (SIX : CURN, « Curatis ») annonce...
Stärkstes Halbjahr in der Unternehmensgeschichte von Curatis – Umsatz steigt um 51 %, deutliche Fortschritte bei Corticorelin (C-PTBE-01)
about 15 hours ago
LIESTAL, Schweiz--(BUSINESS WIRE)--Die Curatis Holding AG (SIX:CURN, „Curatis“) meldet für das erste...
Resumen: El mejor semestre en la historia de Curatis: los ingresos aumentaron un 51 % y se lograron avances significativos con la corticorelina (C-PTBE-01)
about 15 hours ago
LIESTAL, Suiza--(BUSINESS WIRE)--Curatis Holding AG (SIX:CURN, "Curatis") informa ventas netas de bienes...
Samenvatting: Sterkste half jaar in de geschiedenis van Curatis — Inkomsten met 51% gestegen en aanzienlijke vooruitgang in corticorelin (C-PTBE-01)
about 15 hours ago
LIESTAL, Zwitserland--(BUSINESS WIRE)--Curatis Holding AG (SIX:CURN, “Curatis”) rapporteert een neto-omzet uit goederen...
Riassunto: I sei mesi più solidi nella storia di Curatis: ricavi aumentati del 51% e un notevole progresso su corticorelin (C-PTBE-01)
about 15 hours ago
LIESTAL, Svizzera--(BUSINESS WIRE)--Curatis Holding AG (SIX:CURN, “Curatis”) registra ricavi netti dalla vendita...
Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model
about 17 hours ago
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced an extension of its...
SELUTION SLR™ Drug-Eluting Balloon Approved by FDA for In-Stent Restenosis: First and Only Sirolimus Drug-Eluting Balloon in the US
about 17 hours ago
MIAMI LAKES, Fla.--(BUSINESS WIRE)-- #Cordis--Cordis, a global leader in interventional cardiovascular and...
a2z Radiology AI Expands Acute Care Suite with 10 Newly Cleared Findings
about 17 hours ago
BOSTON--(BUSINESS WIRE)-- #MedTech--a2z Radiology AI receives FDA clearance for 10 findings, expanding...